Clinical trials
Withdrawn Observational Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Bayer | 1 |
| British Columbia Cancer Agency | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Geneplus-Beijing Co. Ltd. | 1 |
| Humanity & Health Medical Group Limited | 1 |
| Jae Ho Byun | 1 |
| Methodist Health System | 1 |
| Rush University Medical Center | 1 |
| St. Joseph Hospital of Orange | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 16 |
| Liver Neoplasms | 6 |
| Cholangiocarcinoma | 3 |
| Hepatitis C | 2 |
| Liver Cirrhosis | 2 |
| Anus Neoplasms | 1 |
| Appendiceal Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Ductal | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.